EZH2 mutations in chronic myelomonocytic leukemia cluster with ASXL1 mutations and their co-occurrence is prognostically detrimental

Mrinal M. Patnaik; Rangit Vallapureddy; Terra L. Lasho; Katherine P. Hoversten; Christy M. Finke; Rhett Ketterling; Curtis Hanson; Naseema Gangat; Ayalew Tefferi

doi:10.1038/s41408-017-0045-4

EZH2 mutations in chronic myelomonocytic leukemia cluster with ASXL1 mutations and their co-occurrence is prognostically detrimental

Mrinal M. Patnaik
, Rangit Vallapureddy
, Terra L. Lasho
, Katherine P. Hoversten
, Christy M. Finke
, Rhett Ketterling
, Curtis Hanson
, Naseema Gangat
, Ayalew Tefferi

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Article number	12
Journal	Blood cancer journal
Volume	8
Issue number	1
DOIs	https://doi.org/10.1038/s41408-017-0045-4
State	Published - Jan 1 2018

ASJC Scopus subject areas

Hematology
Oncology

Access to Document

10.1038/s41408-017-0045-4

Cite this

@article{8b5ccaa279f34741bd71b579abddeedb,

title = "EZH2 mutations in chronic myelomonocytic leukemia cluster with ASXL1 mutations and their co-occurrence is prognostically detrimental",

author = "Patnaik, \{Mrinal M.\} and Rangit Vallapureddy and Lasho, \{Terra L.\} and Hoversten, \{Katherine P.\} and Finke, \{Christy M.\} and Rhett Ketterling and Curtis Hanson and Naseema Gangat and Ayalew Tefferi",

note = "Funding Information: Current publication is supported in part by grants from the “The Gerstner Family Career Development Award” and the “Mayo Clinic Center for Individualized Medicine, Mayo Clinic, Rochester, MN, USA”. This publication was supported by CTSA Grant Number KL2 TR000136 from the National Center for Advancing Translational Science (NCATS). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH.",

year = "2018",

month = jan,

day = "1",

doi = "10.1038/s41408-017-0045-4",

language = "English (US)",

volume = "8",

journal = "Blood cancer journal",

issn = "2044-5385",

publisher = "Springer Nature",

number = "1",

}

TY - JOUR

T1 - EZH2 mutations in chronic myelomonocytic leukemia cluster with ASXL1 mutations and their co-occurrence is prognostically detrimental

AU - Patnaik, Mrinal M.

AU - Vallapureddy, Rangit

AU - Lasho, Terra L.

AU - Hoversten, Katherine P.

AU - Finke, Christy M.

AU - Ketterling, Rhett

AU - Hanson, Curtis

AU - Gangat, Naseema

AU - Tefferi, Ayalew

N1 - Funding Information: Current publication is supported in part by grants from the “The Gerstner Family Career Development Award” and the “Mayo Clinic Center for Individualized Medicine, Mayo Clinic, Rochester, MN, USA”. This publication was supported by CTSA Grant Number KL2 TR000136 from the National Center for Advancing Translational Science (NCATS). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH.

PY - 2018/1/1

Y1 - 2018/1/1

UR - https://www.scopus.com/pages/publications/85040983719

UR - https://www.scopus.com/pages/publications/85040983719#tab=citedBy

U2 - 10.1038/s41408-017-0045-4

DO - 10.1038/s41408-017-0045-4

M3 - Letter

C2 - 29358618

AN - SCOPUS:85040983719

SN - 2044-5385

VL - 8

JO - Blood cancer journal

JF - Blood cancer journal

IS - 1

M1 - 12

ER -

EZH2 mutations in chronic myelomonocytic leukemia cluster with ASXL1 mutations and their co-occurrence is prognostically detrimental

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this